On the other hand, the kidney disease risk variants do not replace APOL1 G0 in this regard but rather demonstrate the well-known cellular toxicity that also prevents RCC cell growth and hence tumorigenic potential. This evidence concerns the gene APOL1 and renal cell carcinoma.